Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Weber James HarryExecutive Vice President | Option exercise | M | $67K 940 sh | Jan 23, 2026 |
| 12 | Lail Crystal DawnVP and CFO | Tax withholding | F | $52K 808 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 12 | Ortiz Mauricio AEVP & Chief Accounting Officer | Option exercise | M | $90K 975 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 12 | Alexander Victor BHead of Consumer Bank | Tax withholding | F | $135K 6,236 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 12 | Ladwa AkshayChief Operations Officer | Tax withholding | F | $72K 15.7K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 12 | Ortiz Mauricio AEVP & Chief Accounting Officer | Option exercise | M | $56K 925 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 12 | Horn Daniel E.Chief Commercial Officer | Tax withholding | F | $96K 407 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 11 | Gilliam Joseph EPRESIDENT & COO | Open-market sale · 10b5-1 plan | SELL | $561K 4,502 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 11 | Gan HongCHIEF SCIENCE OFFICER | Open-market sale · 10b5-1 plan | SELL | $250K 100.0K sh | Jan 23, 2026 traded Jan 23, 2026 |
| 11 | Schingler Robert HDirector, Co-Founder Chief Strategy Off. | Tax withholding | F | $488K 18.5K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 11 | Gan HongCHIEF SCIENCE OFFICER | Open-market sale · 10b5-1 plan | SELL | $374K 150.0K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 11 | Edris BadreddinDirector | Option exercise · 10b5-1 plan | M | $5,339 13.7K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 11 | Kirol Charles PeterChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $20K 3,399 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 11 | Edris BadreddinDirector | Option exercise · 10b5-1 plan | M | $11K 17.2K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Vold JeanneVP - Technology | Tax withholding | F | $14K 223 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Velleca Mark A.Director, PRESIDENT & CEO | Grant or award | A | — 600.0K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Ortiz Mauricio AEVP & Chief Accounting Officer | Option exercise | M | $44K 650 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Harrison GilbertDirector | Option exercise | M | — 375 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Tracey KevinDirector | Grant or award | A | — 1,220 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Harrison GilbertDirector | Option exercise | M | — 375 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Weber James HarryExecutive Vice President | Option exercise | M | — 2,475 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | LaFave BleauVP - Bus Dvlpmt & Asset Mgmt | Tax withholding | F | $5,744 89 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Frazier WilliamDirector, Chief Medical Officer | Tax withholding | F | $8,756 1,169 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Stefan Constantin IonelChief Technology Officer | Option exercise | M | — 15.8K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Bensoussan Torres RobertDirector | Option exercise | M | — 375 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Cambre JeromeVice President of Sales | Disposition to issuer | D | $22K 2,930 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Jones Jeffrey J IIDirector | Grant or award | A | — 2,067 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Bensoussan Torres RobertDirector | Option exercise | M | — 375 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Kushel J. RichardSenior Managing Director | Option exercise | M | — 20.0K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Buck ElizabethCHIEF SCIENTIFIC OFFICER | Grant or award | A | — 250.0K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Fitzgerald TraeChief Financial Officer | Disposition to issuer | D | $25K 3,329 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Wiese ChristopherPresident, Energy Vault Labs | Tax withholding | F | $31K 6,808 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Ortiz Mauricio AEVP & Chief Accounting Officer | Option exercise | M | $28K 522 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Frazier WilliamDirector, Chief Medical Officer | Option exercise | M | — 3,401 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Hirano Patricia CSEE REMARKS | Grant or award | A | — 11.9K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Horowitz Jeff PeterChief Compliance Officer | Disposition to issuer | D | — 15.9K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Streeter Jeffrey BDirector | Grant or award | A | $33K 574 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Brennan Ita MDirector | Option exercise | M | — 423 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Ortiz Mauricio AEVP & Chief Accounting Officer | Option exercise | M | — 2,540 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 9 | Huang Michael F.Sr. VP of Clinical Development | Grant or award | A | — 11.9K sh | Jan 23, 2026 traded Jan 21, 2026 |